![Cristhiam Rojas Hernandez MD](https://res.cloudinary.com/els-assets/image/upload/c_fill_pad,f_auto,g_auto,h_150,q_auto,w_120/v1/practice-update/remote-media/contentimage/15749.jpg)
Cristhiam Mauricio Rojas Hernandez MD
Assistant Professor of Hematology, MD Anderson Cancer Center, Houston, TexasDr. Rojas Hernandez is an assistant professor of hematology at the MD Anderson Cancer Center in Houston. He received his medical degree from Universidad del Valle in Cali, Colombia. He completed residency training in internal medicine at Yale University School of Medicine (Bridgeport Hospital), and completed a clinical fellowship in hematology and oncology at the University of New Mexico Health Sciences Center in Albuquerque.
Dr. Rojas Hernandez is actively engaged in research, and has published in numerous peer-reviewed journals. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, among other professional organizations.Disclosures
Disclosures: Daichii Sankyo pharmaceutical for funding in clinical research related to the direct oral anticoagulants.
Recent Contributions to PracticeUpdate:
- Expert Picks From ISTH 2019, Day 2: From Cristhiam Rojas Hernandez
- Management of Hemophagocytic Lymphohistiocytosis in Adults
- Direct Oral Anticoagulants in Patients With Venous Thromboembolism and Thrombophilia
- ASH 2018: Recommendations From Dr. Cristhiam Rojas Hernandez
- 2018 Top Stories in Benign Hematology: The Era of Personalized Treatment of Myeloid Neoplasms: Bringing Genomics to the Bedside
- Tranexamic Acid for the Prevention of Blood Loss After Vaginal Delivery
- A Comprehensive Analysis of Lymphoma-Associated Hemophagocytic Syndrome Detects Clues to Improve Prognosis
- Management of Bleeding in Patients Taking Oral Anticoagulants
- Red Blood Cell Transfusion After a Global Strategy for Early Detection and Treatment of Iron Deficiency Anemia
- Population Impact of Drug Interactions With Warfarin